Skip to main content
logo
Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
9.38
+0.84 (9.84%)
May 5, 2026, 11:03 AM EDT - Market open

Emergent BioSolutions Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
4846445181255922,230
Market Cap Growth
92.82%24.32%313.47%-78.83%-73.47%-53.13%
Enterprise Value
913.951,0111,082873.781,3552,495
Last Close Price
9.3812.369.562.4011.8143.47
PE Ratio
-13.29-2.66-0.16-2.8010.71
Forward PE
----51.157.19
PEG Ratio
----11.760.21
PS Ratio
0.720.870.500.120.531.26
PB Ratio
0.851.231.070.190.431.38
P/TBV Ratio
0.981.341.050.190.431.46
P/FCF Ratio
3.624.1114.47-0.49-3.9523.21
P/OCF Ratio
3.313.778.82-0.61-17.356.96
EV/Sales Ratio
1.351.361.040.831.211.41
EV/EBITDA Ratio
5.484.91144.29-1.51-59.955.32
EV/EBIT Ratio
12.1410.10-9.96-1.20-7.977.31
EV/FCF Ratio
6.756.4530.23-3.39-9.0425.96
Debt / Equity Ratio
1.101.091.371.321.010.52
Debt / EBITDA Ratio
3.502.7888.49-2.20-104.561.86
Debt / FCF Ratio
4.243.6518.54-4.94-15.769.08
Net Debt / Equity Ratio
0.790.701.171.791.240.18
Net Debt / EBITDA Ratio
2.521.7875.23-2.00-76.130.63
Net Debt / FCF Ratio
3.052.3415.76-4.51-11.483.09
Asset Turnover
0.510.550.650.420.360.61
Inventory Turnover
0.921.002.132.081.992.30
Quick Ratio
1.902.191.560.460.652.29
Current Ratio
4.295.013.691.040.983.40
Return on Equity (ROE)
-1.64%10.46%-33.67%-74.67%-14.11%14.35%
Return on Assets (ROA)
-2.89%4.70%-9.03%-30.28%-5.36%8.46%
Return on Invested Capital (ROIC)
-3.67%5.91%-10.89%-39.72%-7.45%12.04%
Return on Capital Employed (ROCE)
5.15%8.29%-9.06%-46.72%-7.52%13.43%
Earnings Yield
-1.76%7.52%-37.66%-618.75%-35.73%9.34%
FCF Yield
27.65%24.35%6.91%-205.86%-25.33%4.31%
Buyback Yield / Dilution
1.26%-6.98%-3.52%-2.20%7.39%-0.56%
Total Shareholder Return
1.26%-6.98%-3.52%-2.20%7.39%-0.56%
Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q